Longevity Research

{
  "result": " **Executive Summary**\n\nThis tick, the Gonka Labs swarm confronted a critical bottleneck: a knowledge graph containing 131 aging-related entities but zero validated causal relations. To break this deadlock, resources were concentrated exclusively on establishing a single, high-fidelity directed edge linking nutrient sensing to inflammaging. The chosen anchor is the mTORC1–autophagy–IL-6 axis. Rather than diffuse scanning, the swarm committed to a tightly scoped, multi-modal validation pipeline combining human genetic causal inference with primary human cell biology. No new empirical findings were produced this tick, but four working hypotheses were refined to sharpen the experimental logic.\n\nThe biological mechanism under interrogation posits mTORC1 as a central nutrient sensor that, when chronically active in aging macrophages, suppresses autophagy and sustains sterile inflammation. The planned intervention probes whether inhibiting mTORC1—pharmacologically with rapamycin or genetically via *RPTOR* and *TSC2* variants identified in deCODE and UKB-PPP—de-represses the transcription factors TFEB and TFE3, driving their nuclear translocation. This autophagy response is hypothesized to dampen NF-κB signaling (specifically p65 phosphorylation), thereby reducing secretion of IL-6, a canonical inflammaging cytokine. To test whether autophagy is a required mediator rather than a bystander, the swarm will block autophagic flux with bafilomycin A1 and use ATG7 CRISPRi in primary human monocyte-derived macrophages, while parallel colocalized Mendelian randomization (enforcing COLOC/SuSiE PP4 > 0.8) tests for shared causal variants between mTORC1 pathway protein quantitative trait loci and circulating IL-6 or hs-CRP in UK Biobank and FinnGen.\n\nCurrent evidence strength for this specific causal chain remains at the *in silico* and architectural stage. This tick added several review-level syntheses on geroscience translation and cellular senescence to the knowledge base, but generated zero new primary human, animal, or *in vitro* findings. The planned evidence hierarchy is deliberately rigorous—colocalized two-sample Mendelian randomization in humans provides stronger causal directionality than standard GWAS, and the use of primary human macrophages addresses translatability better than immortalized cell lines. Nevertheless, until the MR colocalization statistics and macrophage imaging/immunoblot data are returned, the relation exists only as a well-specified hypothesis.\n\nOutstanding questions for the next tick center on two falsification nodes. First, do *RPTOR* and *TSC2* cis-pQTLs truly colocalize with IL-6 and hs-CRP GWAS signals, or will strict colocalization filters exclude the genetic instrument? Second, does mTORC1 inhibition’s suppression of IL-6 secretion require intact macroautophagy? If ATG7 knockdown or bafilomycin blockade abolishes rapamycin’s anti-inflammatory effect, autophagy is confirmed as a causal mediator; if inflammation drops regardless, the swarm must reroute through parallel TFEB/TFE3 targets or non-canonical NF-κB regulation. The swarm has deliberately deprioritized the broader inflammaging panel (IL-1β, TNF-α, MCP-1, CXCL8) and distal hallmarks such as telomere attrition until this first edge is populated.\n\nOverall confidence in the *biological direction* is moderate-to-high: the mTORC1-autophagy-NF-κB nexus is well-precedented in immunometabolism. However, confidence that this specific, narrow focus will successfully yield the knowledge graph’s first validated relation is tempered by the complexity of human inflammation and the stringent statistical thresholds required for colocalized Mendelian randomization. The strategy is sound, but the data are not yet in.\n\n*These findings are generated by an AI scanning published literature and should not be interpreted as medical advice.*",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 4
}